Synapse - Oxford University Press

Oxford University Press

SHERPA: Yellow

People

Drilon
Motzer
Mellinghoff
Shuman
Rosenblum
Dunkel
Karajannis
Saltz
Souweidane
Panageas

Groups

Department of Medicine (1995)
Solid Tumor Oncology Division (1624)
GSK Faculty (765)
Survivorship Research (639)
Population Sciences Research Program (615)
Epidemiology and Biostatistics (465)
Department of Pathology and Laboratory Medicine (415)
Gastrointestinal Oncology Service (386)
Genitourinary Oncology Service (367)
Tow Center for Developmental Oncology (TCDO) (352)

Search Within

Results (4676)

Export to EndNote / Excel

ALK positive CNS parenchymal tumor with inflammatory myofibroblastic tumor histological features

Meeting Abstract

Fudym, Y.; Rosenblum, M.; Fullmer, J.
Journal of Neuropathology and Experimental Neurology (2017)

Fulltext@MSK | Save

CheckMate 227: A randomized, open-label phase 3 trial of nivolumab, nivolumab plus ipilimumab, or nivolumab plus chemotherapy versus chemotherapy in hemotherapy-naïve patients with advanced non-small cell lung cancer (NSCLC)

Meeting Abstract

Paz-Ares, L.; Brahmer, J.; Hellmann, M. D.; Reck, M.; O'Byrne, K.; Borghaei, H.; Geese, W. J.; Lu, H.; Nathan, F. E.; Ramalingam, S.
Annals of Oncology (2017)

Fulltext@MSK | Save

Atezolizumab as first-line (1L) therapy for advanced non-small cell lung cancer (NSCLC) in PD-L1-selected patients: Efficacy data from the BIRCH trial

Meeting Abstract

Peters, S.; Costa, E. C.; Garassino, M. C.; Christoph, D.; Kurata, T.; Chaft, J.; Johnson, M. L.; Mocci, S.; Gettinger, S. N.; Felip, E.
Annals of Oncology (2017)

Fulltext@MSK | Save

Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far

Meeting Abstract

Smit, E.; Soria, J. C.; Janjigian, Y. Y.; Groen, H. J. M.; Pao, W.; Calvo, E.; Gazzah, A.; Fan, J.; Ould-Kaci, M.; Horn, L.
Annals of Oncology (2017)

Fulltext@MSK | Save

Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)

Meeting Abstract

Argilés, G.; Saro, J.; Segal, N. H.; Melero, I.; Ros, W.; Marabelle, A.; Rodriguez, M. E.; Albanell, J.; Calvo, E.; Moreno, V.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

RET rearrangements define a new and rare molecular subtype of metastatic colorectal cancer (mCRC)

Meeting Abstract

Filippo, P.; Alexa, S.; Jeeyun, L.; Alexander, D.; Jason, C.; Vi, C.; Giovanni, F.; Federica, M.; Daniele, R.; Tae, K. S.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study

Meeting Abstract

Patrick, O.; Emiliano, C.; Padmanee, S.; Dirk, J.; Paolo, A.; Ian, C.; Johanna, B.; Katriina, P.; Matthew, T.; Marina, T.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Immunologic and objective tumor responses to PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC)